<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="151">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04337294</url>
  </required_header>
  <id_info>
    <org_study_id>covid19pregnancies</org_study_id>
    <nct_id>NCT04337294</nct_id>
  </id_info>
  <brief_title>Evaluation of Blood Results of Covid 19 Positive Pregnants</brief_title>
  <official_title>Blood Results of Covid 19 Positive Pregnants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kanuni Sultan Suleyman Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kanuni Sultan Suleyman Training and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluation of blood results of covid 19 positive pregnant patients
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 21, 2020</start_date>
  <completion_date type="Anticipated">May 22, 2020</completion_date>
  <primary_completion_date type="Anticipated">May 20, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Months</target_duration>
  <primary_outcome>
    <measure>Examination of changes in blood values of covid 19 positive pregnant patients</measure>
    <time_frame>2 months</time_frame>
    <description>peripheral blood values; hemogram, biochemistry (ast- sub-urea, creatinine, potassium, sodium, calcium, magnesium, vitamin d, homocysteine, ggt, crp)</description>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Covid19</condition>
  <condition>Pregnancy Related</condition>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Evaluation of blood results of covid 19 positive pregnant patients</intervention_name>
    <description>peripheral blood values; hemogram, biochemistry (ast- sub-urea, creatinine, potassium, sodium, calcium, magnesium, vitamin d, homocysteine, ggt, crp)</description>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      peripheral blood values; hemogram, biochemistry (ast- sub-urea, creatinine, potassium,
      sodium, calcium, magnesium, vitamin d, homocysteine, ggt, crp)
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        women with covid 19 positive pregnant women without additional disease and lung disease
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  pregnant

          -  covid19 positive

          -  no lung disease

        Exclusion Criteria:

          -  with lung disease

          -  additional disease

          -  not pregnant pcr test negative
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Pinar Yalcin Bahat</name>
      <address>
        <city>Istanbul</city>
        <state>İ̇stanbul</state>
        <zip>34000</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 5, 2020</study_first_submitted>
  <study_first_submitted_qc>April 5, 2020</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 7, 2020</study_first_posted>
  <last_update_submitted>April 5, 2020</last_update_submitted>
  <last_update_submitted_qc>April 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kanuni Sultan Suleyman Training and Research Hospital</investigator_affiliation>
    <investigator_full_name>Pınar Yalcin bahat</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

